Clinical Trial Results:
A 52-week, randomised, double-blind, placebo-controlled, parallel-group, safety, tolerability and efficacy study of nalmefene, as needed use, in patients with alcohol dependence
Summary
|
|
EudraCT number |
2007-002315-92 |
Trial protocol |
CZ SK EE GB LV HU LT |
Global completion date |
27 Apr 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Mar 2016
|
First version publication date |
26 Mar 2016
|
Other versions |
|
Summary report(s) |
12013A CTgov Result Record |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.